BioNTech, the COVID-19 vaccine maker, will close three sites in Germany after efforts to find buyers for the facilities failed, according to multiple outlets.
Reuters reported that BioNTech will also shutter a site in Singapore, as no buyers emerged for that facility either.
The closures come after the company's attempts to sell the plants did not succeed, according to MarketWatch and Deutsche Welle.
How each side covered it
Center
- Reported that BioNTech will proceed with closing three sites in Germany after failing to find a buyer.
- Reuters noted the closures also extend to a site in Singapore.
- Deutsche Welle grouped the BioNTech news alongside separate, unrelated reporting on Rhine water levels.
“BioNTech to shutter sites in Germany, Singapore as no buyers emerge” — Reuters
Right
- Independent Journal Review reported BioNTech will close three German plants after failing to find buyers.
“BioNTech to close three German plants after failing to find buyers” — Independent Journal Review
Questions readers ask
What happened with BioNTech's German sites?
BioNTech, the COVID-19 vaccine maker, is proceeding with the closure of three sites in Germany after failing to find buyers for the facilities.
Is BioNTech closing sites outside Germany too?
Yes, according to Reuters, BioNTech is also shuttering a site in Singapore after no buyers emerged for that facility.
Why is BioNTech closing these sites?
The sources indicate the closures followed unsuccessful efforts to find buyers for the plants, though the specific reasons for seeking buyers were not detailed in the reports.
Sources · 4 outlet reports
- Deutsche WelleCenterGermany news: COVID vaccine maker BioNTech to close 3 sites
- MarketWatchCenterBioNTech to Proceed With Site Closures After Failing to Find Buyer
- ReutersCenterBioNTech to shutter sites in Germany, Singapore as no buyers emerge
- Independent Journal ReviewRight-leaningBioNTech to close three German plants after failing to find buyers